Naveen Pemmaraju

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Naveen Pemmaraju
Dec 19, 2024, 07:21 | Insight
Post ASH24: The Most Important MPN Studies - IACH
IACH shared a post on X: “Don’t miss out—happening this FRIDAY IACH Webinar:  Post ASH24:…
Dec 16, 2024, 18:10 | Insight
Cellenkos Presented Results of Phase 1b Data for CK0804 T-Regulatory Cell Therapy in Myelofibrosis at ASH 2024
Innovative Cellular Therapy Demonstrated Safety and Potential Clinical Benefit at ASH 2024 Cellenkos, a clinical-stage…
Dec 13, 2024, 19:52 | Blog
Supriya Peshin: It’s truly an honor to meet Naveen Pemmaraju
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X: "Yes, Dr.…
Dec 13, 2024, 15:39 | Societies
Best of 66th ASH Annual Meeting and Exposition
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 12, 2024, 13:11 | Societies
Highlights from Day 4 of 66th ASH Annual Meeting
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 10, 2024, 16:55 | Societies
Highlights from Day 3 of ASH 2024
The 66th ASH Annual Meeting and Exposition held from December 7-10, 2024, in San Diego,…
Dec 10, 2024, 14:00 | Blog
Naveen Pemmaraju: State-of-the-art review of BPDCN
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 10, 2024, 10:40 | Insight
Highlights from ASH24 Day 2
The 66th ASH Annual Meeting and Exposition, is being held from December 7-10, 2024, in…
Dec 9, 2024, 15:53 | Blog
Highlights from ASH Annual Meeting 2024 by Naveen Pemmaraju
The 66th ASH Annual Meeting (ASH24) is taking place from December 7-10, 2024, in San…
Dec 8, 2024, 06:21 | Insight
Understanding and treating myelofibrosis
Nico Gagelmann shared a post on X: "Understanding and treating myelofibrosis A short thread on…
Dec 8, 2024, 06:11 | Societies
Highlights from Day 1 of ASH 2024 Annual Meeting and Exposition
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition is being held from…
Dec 7, 2024, 02:42 | Blog
Naveen Pemmaraju: All about Interferon in MPNSM
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 6, 2024, 16:54 | Insight
Naveen Pemmaraju: How I treat Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 5, 2024, 16:02 | Insight
Naveen Pemmaraju: Our results from the unique MOST observational study
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 4, 2024, 20:32 | Insight
Naveen Pemmaraju: Add-On Therapy with CK0804 in Myelofibrosis Patients with Suboptimal Response to Ruxolitinib
Naveen Pemmaraju shared a post on X: "Highlighting the wonderful work of Dr Lucia Masarova. Prelim/early…
Dec 4, 2024, 18:32 | Insight
Naveen Pemmaraju: Temporal dynamics of BM fibrocytes in the progression of primary MF
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 4, 2024, 18:01 | Blog
Long-term follow-up for patients with APL
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 2, 2024, 22:34 | Blog
Naveen Pemmaraju: ASH Hematology Session on Patient Care, Research and Education on Rare Disease
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 2, 2024, 19:24 | Insight
Naveen Pemmaraju: PVO combination program for frontline CLL treatment
Naveen Pemmaraju shared a post on X: '' ASH Kudos to Dr. Nitin Jain for an…
Dec 2, 2024, 18:18 | Insight
Naveen Pemmaraju: All about RAS pathway mutations in CMML
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 2, 2024, 17:59 | Insight
Naveen Pemmaraju: Pre-clinical Investigation of Tasquinimod for AML Following Myeloproliferative Neoplasm
Naveen Pemmaraju shared a post on X: "Check out our novel Myeloproliferative neoplasm abstract for ASH…
Dec 1, 2024, 21:53 | Blog
Naveen Pemmaraju: Outcomes and Risk Mutations in AYAs with Myeloproliferative Neoplasms
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 1, 2024, 21:26 | Blog
Naveen Pemmaraju: MPNSM Findings from Josef Prchal at LBA-4 at The ASH Annual Meeting
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 1, 2024, 08:51 | Blog
Khalis Mustafayev: Are BCR-ABL1 TKIs safe for cancer patients with chronic Hepatitis C?
KhalisMustafayev, Research Scientist at Miami Cancer Institute, shared on X: "Are BCR::ABL1 TKIs safe for…
Nov 30, 2024, 23:26 | Blog
Naveen Pemmaraju: Highlighting a new BCL-XL degrader in post-MPN AML
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 29, 2024, 15:31 | Insight
Thanksgiving Day 2024: A Time for Gratitude and Reflection
Thanksgiving Day in 2024 fell on November 28th. Thanksgiving Day is a national holiday celebrated…
Nov 27, 2024, 12:59 | Positive
Naveen Pemmaraju: Meeting up with Anirban Maitra in the Faculty Collaborative Space of MD Anderson Cancer Center
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 16, 2024, 20:28 | Insight
Naveen Pemmaraju: Our new report on DDX for mediastinal mass in patient with B-ALL
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 16, 2024, 09:15 | Blog
Naveen Pemmaraju: Current and Future directions in CML
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 12, 2024, 09:49 | Insight
Naveen Pemmaraju: Jason Westin, a tireless advocate for our patients with cancer
Naveen Pemmaraju, Executive Director of MDACC Network, shared on X: “Wonderful to spend time today…
Nov 3, 2024, 16:04 | Blog
Naveen Pemmaraju: Reflecting on the tremendous time spent and powerful discussions at Binaytara Foundation Heme Summit
Naveen Pemmaraju shared on X: "Reflecting on the tremendous time spent and powerful discussions with friends…
Oct 28, 2024, 09:22 | Blog
Naveen Pemmaraju: Lindsay Rein on the latest developments in Systemic Mastocytosis at 16th International MPN Congress
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Oct 26, 2024, 18:22 | Blog
Naveen Pemmaraju: Honored to speak and moderate two key sessions at the 16th International MPN Congress
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Oct 23, 2024, 04:16 | Blog
Naveen Pemmaraju: Annual 5K Walk/Run for Dan’s House of Hope
Naveen Pemmaraju shared on Linkedin: ''Spectacular event and marvelous weather this AM spending time with…
Oct 22, 2024, 23:27 | Blog
Naveen Pemmaraju: Proud to highlight our world-class Leukemia Fellowship
Naveen Pemmaraju Director of BPDCN Program at the University of Texas MD Anderson Cancer Center,…
Oct 22, 2024, 16:41 | Blog
Naveen Pemmaraju: Delighted to have received my copy of The Cancer Journey by Chadi Nabhan
Naveen Pemmaraju shared a post on X: ''Delighted to have received my autographed copy of…
Oct 22, 2024, 02:35 | Blog
Naveen Pemmaraju: Honored to participate in Dan's House of Hope annual 5K walk/run
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Oct 17, 2024, 05:48 | Blog
Sanam Loghavi: A fantastic heme malignancies summit by Binaytara Foundation
Sanam Loghavi shared a post on X. “Thank you Binaytara Foundation, Nitin Jain, and Navneet…
Oct 16, 2024, 13:56 | Blog
Naveen Pemmaraju: Celebrating emerging collaborations across the MD Anderson Cancer Center
Naveen Pemmaraju shared on X: ''Celebrating emerging collaborations across the MD Anderson Cancer Center Cancer…
Oct 16, 2024, 11:41 | Insight
Highlights from the 2024 Summit on Haematological Cancers by The Binaytara Foundation
The 2024 Summit on Haematological Cancers by The Binaytara Foundation took place at the Hutton…
Oct 15, 2024, 12:47 | Blog
Nitin Jain: Wonderful to meet colleagues and friends at the Binaytara Foundation meeting in Nashville
Nitin Jain made the following post on X: “Wonderful to meet colleagues and friends at…
Oct 14, 2024, 15:52 | Blog
Ashwin Kishtagari: Naveen Pemmaraju explores the potential of novel JAK inhibitors in myelofibrosis
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared on X: '' Naveen Pemmaraju explores…
Oct 12, 2024, 11:48 | Blog
Anup Trikannad: Honored to discuss BPDCN with Dr. Naveen Pemmaraju at Grand Rounds at UAMS
Anup Trikannad, Internist in Little Rock, AR, posted on X: "Honored to be with Dr.…
Oct 11, 2024, 17:33 | Insight
Naveen Pemmaraju: Blastic Plasmacytoid Dendritic Cell Neoplasm treatment with focus on SCT
Naveen Pemmaraju shared a post about a recent paper titled "How I treat Blastic Plasmacytoid…
Oct 10, 2024, 13:09 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the…
Oct 1, 2024, 14:07 | Blog
Naveen Pemmaraju: Delighted to speak at the MDACC Cancer Network Partner Summit 2024
Naveen Pemmaraju shared a post on Linkedin: '' This week, I was delighted to attend,…
Sep 26, 2024, 23:57 | Blog
Naveen Pemmaraju: Nice to see so many colleagues form around the world at MPNCoandD Congress
Naveen Pemmaraju shared a post on LinkedIn: " Nice to see so many colleagues form around…
Sep 26, 2024, 16:34 | Blog
Naveen Pemmaraju: Delighted to attend MDACC Cancer Network Partner Summit
Naveen Pemmaraju shared a post on X: ''Delighted to attend our MDACC Cancer Network Partner…
Sep 26, 2024, 15:39 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: "Article of the Week Suggested by the…
Sep 24, 2024, 20:57 | Blog
Talha Badar: A wonderful scientific meeting - IACH2024
Talha Badar shared a post on X: “I want to congratulate Mohamad Mohty, Arnon Nagler,…
Sep 22, 2024, 17:05 | Societies
20 Posts Not To Miss From IACH2024
The 7th Annual Meeting of the International Academy for Clinical Hematology (IACH), featuring the COMydAL, COLYM, and MPNCo&D tracks,…
Sep 22, 2024, 00:11 | Blog
Naveen Pemmaraju: Wonderful to spend time with our brilliant leukemia fellows
Naveen Pemmaraju shared the following on LinkedIn: “Thank you to Guillermo Garcia-Manero MD & Tapan…
Sep 21, 2024, 14:48 | Career
Naveen Pemmaraju receives the IACH 2024 Special Achievement Award
The 7th Annual Meeting of the International Academy for Clinical Hematology (IACH), featuring the COMydAL,…
Sep 19, 2024, 11:07 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: "Article of the Week Suggested by…
Sep 15, 2024, 01:29 | Insight
Naveen Pemmaraju: Thank you for supporting our inaugural MPN Workshop
Naveen Pemmaraju shared a post on X: “ I want to thank everyone who supported…
Sep 13, 2024, 23:49 | Blog
Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting
Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…
Sep 13, 2024, 12:52 | Insight
Naveen Pemmaraju: Recognizing MPN Awareness Day
Naveen Pemmaraju shared a post on LinkedIn: “Recognizing MPN Awareness Day today! Dedicated to all…
Sep 11, 2024, 09:16 | Insight
Naveen Pemmaraju: Pivekimab sunirine in relapsed or refractory acute myeloid leukaemia
Naveen Pemmaraju shared a post on X about a recent paper by Naval Daver et…
Sep 8, 2024, 06:13 | Societies
23 Posts Not To Miss From SOHO2024
The twelfth annual meeting of the Society of Hematologic Oncology (SOHO 2024) was held from…
Sep 2, 2024, 16:02 | Blog
Naveen Pemmaraju: Fantastic venue with mix of pre-clinical and clinical presentations focused on novel pathways in heme malignancies
Naveen Pemmaraju shared on LinkedIn: “I recently gave an invited faculty talk at ISEH -…
Sep 1, 2024, 16:23 | Blog
A conversation about clinical trials with Ruben Mesa and Naveen Pemmaraju
Ruben Mesa shared a post on LinkedIn: ''Excited to share in a patient focused discussion…
Sep 1, 2024, 12:34 | Insight
Highlights from The ISEH 2024
The International Society for Experimental Hematology (ISEH) is a global organization dedicated to the advancement…
Aug 30, 2024, 14:59 | Blog
Naveen Pemmaraju: Proud to have Co-Chaired the inaugural MPN WorkshopNC24 with Ruben Mesa
Naveen Pemmaraju shared on LinkedIn: "Proud to have Co-Chaired the inaugural MPN WorkshopNC24 with my…
Aug 28, 2024, 17:13 | Blog
Ruben Mesa: Fabulous inaugural MPN workshop Carolinas
Ruben Mesa shared a post on LinkedIn: "That’s a wrap, Fabulous inaugural MPN workshop Carolinas brought…
Aug 27, 2024, 12:22 | Insight
Insights from the The MPN Workshop of the Carolinas 2024, August 23-25
The MPN Workshop of the Carolinas aims to deliver the latest insights into the pathogenesis…
Aug 26, 2024, 20:51 | Blog
Naveen Pemmaraju: Honored to be invited speaker at the MPN Patient and Caregiver Workshop
Naveen Pemmaraju shared a post on X: “Honored to be alongside my colleagues to serve…
Aug 24, 2024, 15:53 | Blog
Naveen Pemmaraju: Delighted to spend some time at Atrium Health
Naveen Pemmaraju shared a post on X: "Delighted to spend some time in Charlotte at…
Aug 24, 2024, 12:38 | Societies
Naveen Pemmaraju: Wonderful to kick-off The MPN Workshop of The Carolinas
Naveen Pemmaraju shared on LinkedIn: "Wonderful to kick-off today with my dear friend and colleague,…
Aug 18, 2024, 09:04 | Blog
Naveen Pemmaraju: Excited to Co-Chair MPN Workshop The Carolinas 2024
Naveen Pemmaraju posted on X: "Super excited to Co-Chair this MPN event of the year…
Aug 12, 2024, 22:07 | Blog
Naveen Pemmaraju: When hematology and pathology come together
Naveen Pemmaraju shared on X: "When hematology and pathology come together we are unstoppable! The…
Aug 12, 2024, 13:46 | Blog
Naveen Pemmaraju: The New WHO Classification of Tumors book 5th Edition is now out
Naveen Pemmaraju posted on LinkedIn: "It’s now here! The New WHO Classification of Tumors book…
Aug 11, 2024, 04:37 | Insight
Naveen Pemmaraju: Proud to be a part of the BPDCN chapter in the new WHO Book
Naveen Pemmaraju shared on X: "It’s here! Out now hot off the press! The new…
Aug 10, 2024, 13:10 | Blog
Rahul Banerjee: DAVAHeme Bermuda 2024
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: "DAVAHeme Bermuda 2024.…
Aug 8, 2024, 18:55 | Insight
Naveen Pemmaraju: Wonderful multi-d intellectual meet-up of the minds
Naveen Pemmaraju shared on X: “Thanks to Rizwan Romee’s visit, a Wonderful multi-d intellectual meet-up of…
Aug 4, 2024, 10:17 | Blog
Naveen Pemmaraju: Intersection of neurosurgery and leukemia from two Johns Hopkins alums
Naveen Pemmaraju shared on X: "Excellent discussion together today intersection of neurosurgery Shaan M. Raza and…
Aug 1, 2024, 14:55 | Blog
Naveen Pemmaraju: Honored to be a featured MPN faculty speaker for upcoming Research Town Hall on Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: "Honored to be a featured MPN faculty speaker…
Jul 30, 2024, 07:14 | Blog
Naveen Pemmaraju: Superb clinic and research teams working together in Team Pemm clinic
Naveen Pemmaraju shared a post on X: "Superb clinic and research teams working together in…
Jul 29, 2024, 00:13 | Blog
Naveen Pemmaraju: Congratulations to Jane Waukau on her retirement as a Research Nurse Supervisor
Naveen Pemmaraju posted on X: "Congratulations to Jane Waukau on her retirement as a phenomenal…
Jul 26, 2024, 13:51 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Naveen Pemmaraju
We are excited to feature Dr. Naveen Pemmaraju, a prominent expert in the field of…
Jul 24, 2024, 06:20 | Blog
Naveen Pemmaraju: Co-chairing the inaugural International Workshop on MPN24 meeting
Naveen Pemmaraju shared on LinkedIn: "I recently had the opportunity to co-chair with Prof Claire…
Jul 22, 2024, 13:23 | Blog
Naveen Pemmaraju: CK0801 in Treatment of Bone Marrow Failure Syndromes
Naveen Pemmaraju posted on X about recent paper by Tapan M. Kadia et al., commenting:…
Jul 22, 2024, 07:38 | Blog
Naveen Pemmaraju: MPN Workshop of the Carolinas 2024
Naveen Pemmaraju shared on X: "Delighted to invite you to join us MPNCarolinas24 Aug 23-35,2024 Asheville,…
Jul 21, 2024, 21:44 | Blog
Naveen Pemmaraju: Delighted to serve as a speaker at the recent AML-ALL US Focus meeting
Naveen Pemmaraju shared on LinkedIn: "I was delighted to serve as an invited faculty speaker…
Jul 20, 2024, 14:27 | Insight
Naveen Pemmaraju: Important paper on AML and Hyperleukocytosis
Naveen Pemmaraju shared a post about a paper titled "Outcomes of Patients With Newly Diagnosed…
Jul 19, 2024, 13:27 | Insight
Fadi Haddad: Hyperleukocytosis in Acute myeloid leukemia
Fadi Haddad, Assistant Professor at Leukemia Department at MD Anderson Cancer Center, shared a post…
Jul 18, 2024, 08:49 | Insight
Naveen Pemmaraju: Wonderful to catch up with Hannah Goulart
Naveen Pemmaraju shared a post on X about a recent article titled "Myeloproliferative neoplasms in…
Jul 17, 2024, 21:49 | Blog
Daily oral zelenirstat for advanced solid tumors and R/R B-cell lymphomas
Naveen Pemmaraju shared on X: ''A first-in-human phase I trial of daily oral zelenirstat, a…
Jul 15, 2024, 12:27 | Blog
Naveen Pemmaraju welcomes Charan Thej Reddy Vegivinti to MD Anderson Cancer Center team
Naveen Pemmaraju’s shared a post on X: “Welcome to MD Anderson Cancer Center Charan Thej…
Jul 15, 2024, 06:09 | Insight
Naveen Pemmaraju: Superb talk on developing immune-targeting agents in AML
Naveen Pemmaraju shared on X: "Absolutely superb talk by Dr Yasmin Abaza at AML-ALL US…
Jul 14, 2024, 07:11 | Blog
Naveen Pemmaraju: Nitin Jain and Rami Komrokji kick off the US AML-ALL Focus meeting
Naveen Pemmaraju shared a post on X:   . "Superb talks by Nitin Jain on Highlights…
Jul 12, 2024, 16:59 | Insight
Naveen Pemmaraju: Two of the finest people I have ever known
Naveen Pemmaraju shared a post on X: “Just landed MD Education AML-ALL US Focus meeting…
Jul 9, 2024, 03:14 | Insight
Naveen Pemmaraju: MPN AYA state-of-the-art review
Naveen Pemmaraju shared a post on X: “MPN AYA state-of-the-art review led by Hannah Goulart…
Jul 8, 2024, 05:08 | Blog
Ruben Mesa: Join us for this clinically focused MPN workshop
Ruben Mesa shared a post by the European School of Haematology (ESH) on LinkedIn, adding:…
Jul 7, 2024, 10:40 | Insight
Distinction of AA vs inherited BM failure syndromes
Naveen Pemmaraju shared on X: "Our article just out in Clinical Lymphoma Myeloma Leukemia (CLML)…
Jul 4, 2024, 00:54 | Blog
The Story Behind the Story with Dr. Naveen Pemmaraju
Naveen Pemmaraju shared a post on X: "Honored to be featured on an episode of…
Jul 3, 2024, 22:53 | Blog
Naveen Pemmaraju congratulates new interns, reflecting back on his first year
Naveen Pemmaraju shared on X: "Wishing all a Happy July 1st! Shout outs go to…
Jul 2, 2024, 12:28 | Blog
Naveen Pemmaraju: Co-chairing with Claire Harrison at iwMPN
Naveen Pemmaraju shared a post on X: “International Workshop on Myelodysplastic Syndromes & Myeloproliferative Neoplasms…
Jul 2, 2024, 08:18 | Blog
Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…
Jun 29, 2024, 16:57 | Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 25, 2024, 16:07 | Blog
Join IACH for the upcoming IACH Post EHA and ASCO webinar
The International Academy for Clinical Hematology shared on X/Twitter: "Join us for the upcoming IACH…
All: 211 Posts: 1 - 100
Special Coverage